Psychopharmacology

, Volume 121, Issue 4, pp 485–487 | Cite as

Vesamicol, an acetylcholine uptake blocker in presynaptic vesicles, suppresses rapid eye movement (REM) sleep in the rat

  • R. J. Salin-Pascual
  • A. Jimenez-Anguiano
Original Investigation

Abstract

Vesamicol inhibits acetylcholine uptake in presynaptic vesicles and reduces its release. The present study was performed in order to test the effects of this drug in a cholinergic related function as rapid eye movement (REM) sleep. Wistar male rats were implanted for sleep recordings. In addition, a stainless steel cannula was implanted into the left lateral ventricle for intracerebroventricular (ICV) injections. In experiment 1, a dose-response curve was performed. Saline or vesamicol (20, 40, 80 and 100 µg) were injected. Following the ICV injections, animals' sleep was recorded for 8 h. In experiment 2, after adaptation and baseline recordings, animals received 50 µg vesamicol ICV at 1000 hours. every 24 h for 2 consecutive days. After each injection an 8-h sleep recording session was performed. Two subsequent recovery recordings were allowed. Results obtained in experiment 1 showed a dose-response reduction of REM sleep with significant values at 80 µg and 100 µg of vesamicol. The main findings in experiment 2 were a reduction in REM sleep time and an increases in REM sleep latency. On the recovery days, a dramatic rebound of REM sleep was observed. Vesamicol behaved as an anticholinergic drug. It produced a reduction in REM sleep time and a rebound of this sleep stage after its withdrawal.

Key words

Vesamicol Acetylcholine REM sleep Sleep Rats 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baghdoyan HA, Rodrigo-Angulo ML, McCarley RW, Hobson JA (1987) A neuroanatomical gradient in the pontine tegmentum for the cholinoceptive induction of desynchronized sleep signs. Brain Res 414:214–245CrossRefGoogle Scholar
  2. Bahr BA, Parsons SM (1992b) Purification of the vesamicol receptor. Biochemist 31:5763–5769CrossRefGoogle Scholar
  3. Bahr BA, Clarkson ED, Rogers GA, Noremberg K, Parson SM (1992) A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles. Biochemist 31:5752–5762CrossRefGoogle Scholar
  4. Buccafusco JJ, Wei J, Kraft KL (1991) The effect of the acetylcholine transport blocker vesamicol on central cholinergic pressor neurons. Synapse 8:301–306CrossRefPubMedGoogle Scholar
  5. Domino EF, Yamamoto K, Dren AT (1968) Role of cholinergic mechanisms in state of wakefulness and sleep. Prog Brain Res 28: 113–133PubMedGoogle Scholar
  6. Gillin JC, Salín-Pascual RJ, Velazquez-Moctezuma J, Shiromani P, Zoltoski R (1993) Cholinergic receptor subtypes and REM sleep in animals and normal controls. In: Cuello AC (ed) Progress in brain research 98. Elsevier, Amsterdam, pp 379–387Google Scholar
  7. Hernández-Peón R, Chávez-Ibarra G, Morgane PJ, Timo-Iaria C (1963) Limbic cholinergic pathways involved in sleep and emotional behavior. Exp Neurol 163 8:93–111CrossRefGoogle Scholar
  8. Marien MR, Richard JW, Allaire C, Altar CA (1991) Suppression of in vivo neostriatal acetylcholine release by vesamicol: evidence for a functional role of vesamicol receptors in brain. J Neurochem 57:1878–1883PubMedGoogle Scholar
  9. Parsons SM, Prior C, Marshall IG (1993) Acetylcholine transport, storage and release. Int Rev Neurobiol 35:279–390PubMedGoogle Scholar
  10. Salín-Pascual RJ, Jimenez-Anguiano A, Granados-Fuentes D, Drucker-Colín R (1992) Effects of biperiden on sleep at baseline and after 72 h of REM sleep deprivation in the cat. Psychopharmacology 106:540–542CrossRefPubMedGoogle Scholar
  11. Sutin EL, Shiromani P, Kelsoe JR, Storch FI, Gillin JC (1986) Rapid eye movement sleep and muscarinic receptors binding in rats are augmented during withdrawal from chronic scopolamine treatment. Life Sci 39:2419–2427CrossRefPubMedGoogle Scholar
  12. Ursin R, Sterman MB (1968) A manual for standard scoring of sleep waking states in the adult cat. UCLA, Public Services Dept, Los Angeles, Calif.Google Scholar
  13. Velázquez-Moctezuma J, Gillin JC, Shiromani PJ (1989) Effect of Specific M1, M2 muscarinic receptor agonist on REM sleep generation. Brain Res 503:128–131Google Scholar
  14. Zoltoski RK, Velazquez-Moctezuma J, Shiromani P, Gillin JC (1993) The relative effect of selective M1 muscarinic antagonist on rapid eye movement sleep. Brain Res 608:186–190CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • R. J. Salin-Pascual
    • 1
  • A. Jimenez-Anguiano
    • 2
  1. 1.Departamento de fisiologia, Facultad de MedicinaUniversidad Nacional Autonoma de MexicoMexico
  2. 2.Instituto de Fisiologia CelularUniversidad Nacional Autonoma de MexicoMexico

Personalised recommendations